1. Catalogs
  2. Agilent Technologies - Life Sciences and Chemical
  3. Drugs of Abuse Method Development Guide

Drugs of Abuse Method Development Guide

Drugs of Abuse Method Development Guide
1 / 12 PagesView full catalog

Drugs of Abuse Method Development Guide

Product catalog summary
Introduction
LC/MS methods are increasingly preferred for drug screening and confirmation due to their simplicity and efficiency compared to GC/MS methods. Agilent provides technologies to enhance these methods.
Key Workflow Considerations
Sample matrices such as blood, plasma, and urine can affect analytical systems, necessitating reliable sample preparation. The selection of columns and sample prep techniques should consider time, cost, and performance. Ion suppression from sample matrices can impact MS results, especially with electrospray sources. Analyzing drugs of abuse is challenging due to their volatility and interaction with materials.
Testing Stages for Drugs of Abuse
General Drug Screening: Utilizes generic sample preparation to handle a wide range of compounds efficiently.
Confirmatory Tests: Focuses on specific drugs or classes to achieve low detection limits and high throughput.
Sample Preparation Protocols
Various techniques are discussed, including Filtration/Dilute-and-Shoot, Liquid-Liquid Extraction, Solid-Supported Liquid Extraction, Protein Precipitation, Phospholipid Removing Cartridges/Plates, and Solid Phase Extraction, each with its advantages and limitations.
Method Development Considerations
Specific considerations for different drugs such as Amphetamines, 6-Acetylmorphine, Buprenorphine/Norbuprenorphine, Phencyclidine (PCP), 11-Nor-9-carboxy-Δ9-tetrahydrocannabinol (THCA), Benzoylecgonine (BE), and Opiates (Morphine, Codeine) are outlined, focusing on sample prep and elution techniques.
Choosing the Right Sample Prep Technique
Methods should be selected based on analytical goals, regulatory requirements, and cost considerations. Mixed-mode solid phase extraction offers flexibility for both screening and confirmation.
Common Forensic Sample Prep Challenges
Challenges include balancing throughput with data integrity and cost-efficiency, the need for non-group-specific methods for screening and selective methods for confirmation, ensuring high recoveries to avoid false positives, and effective sample cleanup to meet low detection limits.
Agilent Bond Elut Plexa PCX
A versatile choice for forensic applications, accommodating a wide range of analytes with high sensitivity and reproducibility.
Sample Elution Strategies
Strategies include using strong bases for basic analytes and organic solvents for neutral/acidic analytes, optimizing solvent-analyte interaction with soaking procedures, and controlled elution.
Sample Preparation Workflow Recommendations
For Bond Elut Plexa PCX, the document outlines the sample drying process, involving pulling air through a vacuum manifold for specific durations depending on the sorbent bed size.
LC Column Selection
The importance of selecting the right LC column is emphasized to process samples quickly without compromising accuracy. Poroshell 120 columns are recommended for their robustness, less clogging, fast separations, and excellent column capacity.
Improving Resolution and Selectivity
Resolution can be increased by using columns with smaller-diameter media, while selectivity can be improved by altering mobile phase composition, column temperature, and stationary phase composition.
Method Parameters
Gradient methods are recommended to improve speed and separation. A suggested starting gradient for drugs of abuse is provided, along with advice on column equilibration and capillary selection to minimize extra column volume.
Optimizing MS Results
Tips include using dynamic MRM for analyzing multiple compounds, starting LC analysis with a low fraction of organic solvent, and using low injection volumes to prevent detector overload.
Agilent Forensic Toxicology LC/MS Application Kits
These kits are designed for quick and efficient method development and include LC columns, analytical standards, LC/MS methods, databases, libraries, and on-site application support.
Ordering Information
Part numbers for various Agilent products related to drugs of abuse analyses are provided, with directions to Agilent's website for a full list of sample prep products.
See more

Catalog excerpts

Drugs of Abuse Method Development Guide-1

LC/MS methods are rapidly becoming an important O tool for drug screening and confirmation because OO they typically don’t require a derivatization step, and are often less complicated than GC/MS methods. O You can simplify and optimize method development even further using new technologies from Agilent. O QUICK-REFERENCE METHOD GUIDE N CH 3 KeyC workflow considerations: H NH 2 H2 H NNH2 C C C C • epending on the C analytical instruments used, sample matrices – such as O CD H H Hblood, plasma, and urine – can adversely affect your system and columns. H H H Accordingly, reliable sample prep is an essential part of the workflow. O H3 • olumns and sample prep techniques should beCselected with an eye C H O NH toward return on investment – specifically, time and cost2 when compared C C to workflow performance and results. O H H • hen using an electrospray source, ion suppression caused by sample W matrices can negatively impact your MS results. O • any drugs of abuse are challenging to analyze because of factors, such as M volatility, hydrophobicity, and “stickiness” to glass and plastic.

 Open the catalog to page 1
Drugs of Abuse Method Development Guide-2

WHAT YOU’LL FIND IN THIS GUIDE Although both liquid chromatography and gas chromatography can be used for bioanalytical and forensics applications, this guide will focus on the LC/MS workflow. Depending upon the stage of testing you perform – and your ability to modify methods – the insights you find in this guide may help you improve throughput and results. Key information is organized as follows: • Outer panels: General overview, plus tips for working with analytes commonly targeted in drugs of abuse testing. • Center panels: Workflow recommendations for sample prep, separation, and detection....

 Open the catalog to page 2
Drugs of Abuse Method Development Guide-3

SAMPLE PREP PROTOCOLS: DRUGS OF ABUSE Sample filtration/ dilute-and-shoot Protocols Liquid-liquid extraction Solid-supported liquid extraction Protein precipitation Phospholipid removing cartridges/plates • dd water-immiscible A solvents (i.e. methylene chloride) and biological sample in a container •Apply biological sample to solid-supported liquid extraction plate or cartridge (pre-treat if needed) and organic solvent (such as acetonitrile) in a centrifugation vial • dd biological sample and A organic solvent (such as acetonitrile) to phospholipidremoving plate or cartridge • ix container thoroughly...

 Open the catalog to page 3
Drugs of Abuse Method Development Guide-4

TIPS AND TOOLS: DRUGS OF ABUSE SEPARATIONS METHOD DEVELOPMENT CONSIDERATIONS Sample Prep Column Selection/Separation • an evaporate at the sample prep C extraction solvent evaporation step unless precipitated as salts by adding hydrochloric acid • Add HCl toward the end of evaporation to avoid formation of ammonium chloride salts, which cause ion suppression • oroshell 120 EC-C18, 3 x 50 mm provides excellent separation of P amphetamines and structurally similar drugs, such as ephedrine and its stereoisomer pseudoephedrine (as required by SAMHSA) • Recovery of longer-chain non-polar amphetamines...

 Open the catalog to page 4
Drugs of Abuse Method Development Guide-5

TIPS AND TOOLS: DRUGS OF ABUSE SEPARATIONS continued ANALYTE METHOD DEVELOPMENT CONSIDERATIONS CHARACTERISTICS • Highly non-polar (Log P >6) Sample Prep Column Selection/Separation • ticks to glassware, LC tubing, and injector S parts • Deactivated vials/inserts and MeOH-rinsed/air-dried glassware recommended • Found in urine in a form of glucuronide conjugates • AMHSA requires converting glucuronides to THCA (most reliable conversion S method is base hydrolysis – incubation with KOH at 60 °C) • obile phase: A - 5 mM ammonium format in water; B - 100% M methanol • arboxylic acid; retained on...

 Open the catalog to page 5
Drugs of Abuse Method Development Guide-6

HOW DO I CHOOSE THE RIGHT SAMPLE PREP TECHNIQUE? Select your sample prep method with your analytical goals and requirements in mind – including your lab affiliation/profile, regulatory environment, matrix, target analytes, cost considerations, and detection method. There is no standard procedure for defining a comprehensive sample preparation method, and various published procedures are often complementary, because they focus on different targeted analytes. Selecting a flexible sample preparation approach such as mixed-mode solid phase extraction (SPE) gives you a versatile tool for sample cleanup,...

 Open the catalog to page 6
Drugs of Abuse Method Development Guide-7

Sample prep workflow recommendations for Bond Elut Plexa PCX Conditioning • onditioning with methanol is sufficient; equilibration with water not C needed. Sample loading • cidification (pH<6) recommended for basic and acidic analytes. A Allow samples to drip by gravity, or apply low vacuum (2-3” Hg). Wash 1 • Acidified aqueous wash for all analytes – use 2% formic acid Wash 2 • % methanol wash for most acidic and neutral analytes - test if higher 5 proportion of organic can be used without leading to analyte breakthrough • 00% methanol wash for most basic analytes (at this step, acidic/neutral...

 Open the catalog to page 7
Drugs of Abuse Method Development Guide-8

WHICH LC COLUMN IS BEST FOR MY APPLICATION? You are likely under pressure to process more samples, faster – without compromising accuracy; therefore, you need to consider several factors during LC column selection. For example, poor column robustness can reduce column lifetime and lead to costly rework. In addition, samples with high analyte concentrations may require a column with higher capacity. A robust first choice for drugs of abuse: Poroshell 120 columns F ast Guards for UHPLC are also available to further extend column lifetime without reducing Fast LC performance. • ast separations with...

 Open the catalog to page 8
Drugs of Abuse Method Development Guide-9

Choosing the right mobile phase • Mobile Phase B: 0.1% formic acid in methanol Part Number Includes one each of Poroshell 120 EC-C18, Phenyl-Hexyl and Bonus-RP • Mobile Phase A: 0.1% formic acid in water A good general mobile phase for basic drugs of abuse applications is: Includes one each of Poroshell 120 SB-Aq, Phenyl-Hexyl and Bonus-RP For THCA, use 5 mM ammonium formate in water for A, and 100% methanol for B. Optimizing column temperature For maximum column lifetime, you should generally run your analyses below 40 °C. More kits are available for other Agilent columns; see agilent.com/chem/methoddevkits...

 Open the catalog to page 9

All Agilent Technologies - Life Sciences and Chemical catalogs and technical brochures

  1. MS500

    12  Pages

  2. 4200 MP-AES

    12  Pages

  3. Agilent B1507A

    22  Pages

  4. Agilent M9703A

    16  Pages

  5. I/O Hardware

    16  Pages

  6. VEE 9.32

    24  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.